Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market [Yahoo! Finance]
Integra LifeSciences (IART) had its price target lowered by Wells Fargo & Company from $13.00 to $12.00. They now have an "equal weight" rating on the stock.
Integra LifeSciences Q4 Earnings Call Highlights [Yahoo! Finance]
Integra LifeSciences (IART) Stock Trades Down, Here Is Why [Yahoo! Finance]
Integra LifeSciences (NASDAQ:IART) Surprises With Q4 CY2025 Sales [Yahoo! Finance]